UBC Medical Indonesia Tbk. vs WIR ASIA Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while WIR ASIA Tbk. trades at Rp53 (market cap 632.75B, 74.95M 24h volume). The key difference: UBC Medical Indonesia Tbk. and WIR ASIA Tbk. are close in size by market cap, and WIR ASIA Tbk. is more actively traded (74.95M versus 3.48M). Which is the better fit depends on your goals.
| LABS | WIRG | |
|---|---|---|
Market Cap | 576.7B | 632.75B |
Volume | 3.48M | 74.95M |
Lot | 34.82K | 749.53K |
Turnover | 522.79M | 3.97B |
Average Price | 150.13 | 53.02 |
Value | 522.79M | 3.97B |
Indicative Equilibrium Price | 148 | 53 |
Indicative Equilibrium Volume | 350 | 23.65K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →